ZVRA · Categories · Form 4
ZVRA - SEC Form 4 insider transactions
Zevra Therapeutics Inc. (ZVRA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for ZVRA
- SEC Form 4 filed by SVP, Finance & Corp Controller Sangiovanni Timothy J.4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- Chief Legal & Compliance Thompson Rahsaan sold $20,272 worth of shares (1,794 units at $11.30) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 48,125 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Bode John B4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Renz Justin A4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- President and CEO Mcfarlane Neil F. converted options into 37,500 shares and sold $125,186 worth of shares (14,625 units at $8.56), increasing direct ownership by 6% to 387,225 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SVP, Finance & Corp Controller Sangiovanni Timothy J. sold $27,548 worth of shares (3,000 units at $9.18), decreasing direct ownership by 9% to 29,590 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- CCO Schafer Joshua sold $96,500 worth of shares (10,500 units at $9.19), decreasing direct ownership by 14% to 62,278 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SVP, Finance & Corp Controller Sangiovanni Timothy J. sold $15,442 worth of shares (1,750 units at $8.82) and converted options into 17,999 shares, increasing direct ownership by 99% to 32,590 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- Chief Legal & Compliance Thompson Rahsaan converted options into 11,333 shares and sold $36,010 worth of shares (4,080 units at $8.83), increasing direct ownership by 17% to 49,919 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- CCO Schafer Joshua sold $29,800 worth of shares (3,375 units at $8.83) and converted options into 46,667 shares, increasing direct ownership by 147% to 72,778 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- Chief Medical Officer Quartel Adrian W converted options into 11,333 shares and sold $40,036 worth of shares (4,533 units at $8.83), increasing direct ownership by 233% to 9,723 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- President and CEO Mcfarlane Neil F. converted options into 233,334 shares and sold $853,425 worth of shares (91,000 units at $9.38), increasing direct ownership by 64% to 364,350 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- Former CFO & Treasurer Clifton R. Laduane converted options into 140,667 shares and covered exercise/tax liability with 48,513 shares, increasing direct ownership by 179% to 143,515 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Director Secor Alicia4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- President and CEO Mcfarlane Neil F. converted options into 50,000 shares and sold $210,908 worth of shares (19,500 units at $10.82), increasing direct ownership by 16% to 222,016 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- Chief Legal & Compliance Thompson Rahsaan sold $221,004 worth of shares (24,000 units at $9.21), decreasing direct ownership by 36% to 42,666 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- Chief Legal & Compliance Thompson Rahsaan converted options into 66,666 shares (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Director Shih Alvin4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Director Dixon Wendy L4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Director Calder Douglas W4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Director Favorito Tamara A4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Director Watton Corey Michael4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Director Bode John B4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Director Anderson Thomas4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Quartel Adrian W4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SVP, Finance & Corp Controller Sangiovanni Timothy J. sold $23,588 worth of shares (3,000 units at $7.86), decreasing direct ownership by 16% to 16,341 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- CCO & EVP, Bus. Development Schafer Joshua sold $82,527 worth of shares (10,500 units at $7.86), decreasing direct ownership by 26% to 29,486 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- CFO & Treasurer Clifton R. Laduane sold $86,471 worth of shares (11,000 units at $7.86), decreasing direct ownership by 18% to 51,361 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- President and CEO Mcfarlane Neil F. sold $727,390 worth of shares (91,817 units at $7.92), decreasing direct ownership by 32% to 191,516 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by President and CEO Mcfarlane Neil F.4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SVP, Finance & Corp Controller Sangiovanni Timothy J. converted options into 11,666 shares, increasing direct ownership by 152% to 19,341 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Chief Legal & Compliance Thompson Rahsaan4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- CCO & EVP, Bus. Development Schafer Joshua converted options into 35,333 shares, increasing direct ownership by 759% to 39,986 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- CFO & Treasurer Clifton R. Laduane converted options into 43,333 shares, increasing direct ownership by 228% to 62,361 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- President and CEO Mcfarlane Neil F. converted options into 233,333 shares, increasing direct ownership by 467% to 283,333 units (SEC Form 4)4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Chief Legal & Compliance Thompson Rahsaan4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Bode John B4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Dixon Wendy L4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Favorito Tamara A4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Calder Douglas W4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Watton Corey Michael4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Shih Alvin4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
- SEC Form 4 filed by Anderson Thomas4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)